Metraipolis › archive › dc_d03e6f468674

CDK8 remodels the tumor microenvironment and promotes resistance to KRASG12D inhibitors and daraxonrasib in PDAC — Europe PMC PMID:42436354

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42436354
DOI
10.1038/s44318-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-10-18T08:07:29.093Z
SHA-256 of the archived text
54fb5df086342b4b3febe18b457e64091411aea39fc42274d8736175b7dc3dad
Stable URL of this page
https://metraipolis.com/documento/dc_d03e6f468674

How to cite

CDK8 remodels the tumor microenvironment and promotes resistance to KRASG12D inhibitors and daraxonrasib in PDAC — Europe PMC PMID:42436354 — Europe PMC (en), https://europepmc.org/article/MED/42436354 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d03e6f468674 (Metraipolis archive dc_d03e6f468674, sha256 54fb5df086342b4b3febe18b457e64091411aea39fc42274d8736175b7dc3dad)
BibTeX
@misc{dcd03e6f468674,
  title = {CDK8 remodels the tumor microenvironment and promotes resistance to KRASG12D inhibitors and daraxonrasib in PDAC — Europe PMC PMID:42436354},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42436354},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d03e6f468674; sha256 54fb5df086342b4b3febe18b457e64091411aea39fc42274d8736175b7dc3dad},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42436354. Agents can read the archived copy with the MCP tool read_document.